NCT00019344 2015-04-29Flavopiridol in Treating Patients With Refractory CancerNational Cancer Institute (NCI)Phase 1 Completed
NCT00082784 2014-12-23Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsNational Cancer Institute (NCI)Phase 1 Completed93 enrolled
NCT00058227 2013-06-04Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed37 enrolled